Catalyst Wire Dossier Catalyst Wire Dossier

Anti-CD3 & Anti-CD7 Ricin A Immunotoxin

CD3/CD7-targeted ricin A immunotoxin · Henogen
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-CD3 & Anti-CD7 Ricin A Immunotoxin, covering 2009-04-29 to 2009-04-29. Get the full timeline:

Most recent: Clinical Trial Update: Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host Disease [Phase 1, Phase 2]

See pricing